GANX Competitors & Alternatives
Compare Gain Therapeutics Inc with similar stocks in the same industry
Biotechnology
GANX
Main Stock$1.76
Tradestie Score
52
Market Cap
$65.43M
Revenue Growth
-1.0%
Analyst Upside
+331.8%
Top Competitors
228 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
STTK
Shattuck Labs, Inc. Common Stock
|
$7.09
|
$114.01M | - | 61 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$24.30
|
$110.20M | - | 52 | Compare |
|
COYA
Coya Therapeutics, Inc. Common Stock
|
$4.07
|
$97.84M | - | 48 | Compare |
|
HOWL
Werewolf Therapeutics, Inc. Common Stock
|
$0.68
|
$89.17M | - | 47 | Compare |
|
CNTB
Connect Biopharma Holdings Limited Ordinary Shares
|
$2.53
|
$83.60M | - | 45 | Compare |
|
STRO
Sutro Biopharma, Inc.
|
$35.39
|
$76.55M | - | 54 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$7.37
|
$71.69M | - | 59 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$8.63
|
$67.94M | - | 56 | Compare |
|
INAB
IN8bio, Inc. Common Stock
|
$1.51
|
$10.26M | - | 57 | Compare |
|
FNCHQ
FNCHQ
|
- | - | - | - | Compare |
More GANX Analysis
Data updated: Apr 29, 2026 | Industry: Biotechnology (SIC 2834)
228 stocks in this industry